A detailed history of Gamma Investing LLC transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 235 shares of SLP stock, worth $7,477. This represents 0.0% of its overall portfolio holdings.

Number of Shares
235
Previous 162 45.06%
Holding current value
$7,477
Previous $7.88 Million 4.46%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$30.46 - $46.86 $2,223 - $3,420
73 Added 45.06%
235 $7.53 Million
Q2 2024

Jul 02, 2024

BUY
$38.46 - $50.95 $3,461 - $4,585
90 Added 125.0%
162 $7.88 Million
Q1 2024

Apr 05, 2024

BUY
$37.48 - $44.74 $2,211 - $2,639
59 Added 453.85%
72 $2.96 Million
Q4 2023

Feb 01, 2024

BUY
$33.36 - $45.71 $433 - $594
13 New
13 $493,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $646M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.